Table 3.

Other adverse events observed during 6 months of follow-up

	DEX implant group (n=18)	IVTA group (n=25)	P-value
Secondary infection	0	0	–
Endophthalmitis	0	0	–
Noninfectious inflammation	0	0	–
Retinal detachment	0	0	–
Conjunctival hemorrhage	4 (22.2)	2 (8)	0.184
Implant migration	0	0	–
Eye pain	5 (27.8)	8 (32)	0.766

Notes: Among-group comparison using Fisher’s exact t-test, P-values <0.05 were considered to be statistically significant. Data are presented as n (%) unless otherwise indicated.

Abbreviations: DEX, dexamethasone; IVTA, intravitreal triamcinolone acetonide.